You are viewing the site in preview mode

Skip to main content

Advertisement

Table 5 Clinical outcomes for patients according to demographic characteristics of interest (clinically evaluable population at the post-therapy/test of cure visit)

From: Efficacy and safety of telithromycin 800 mg once daily for 7 days in community-acquired pneumonia: an open-label, multicenter study

  Clinical Outcome
Subgroup n Clinical cure, n (%)
All patients 357 332 (93.0)
Bacteremia 14 14 (100)
S pneumoniae bacteremia 9 9 (100)
Age ≥ 65 years 47 45 (95.7)
Chest x-ray findings   
   Unilateral 256 236 (92.2)
   Bilateral 97 92 (94.8)
   Single lobe* 303 282 (93.1)
   Multiple lobes 42 38 (90.5)
Fever >38°C (oral or equivalent) 123 117 (95.1)
PSI   
   Class I 187 176 (94.1)
   Class II 126 115 (91.3)
   Class III 35 32 (91.4)
   Class IV 9 9 (100)
  1. PSI = pneumonia severity index.
  2. *"Single lobe" could apply to either unilateral or bilateral lung involvement (i.e. 1 lobe per right and/or left lung).